{"id":"W2063358281","doi":"10.1097/hjh.0b013e3282f3ad9a","title":"Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial","year":2008,"lang":"en","type":"article","venue":"Journal of Hypertension","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Ramipril; Aliskiren; Hydrochlorothiazide; Blood pressure; Tolerability; Placebo; Urology; Ambulatory blood pressure; ACE inhibitor; Adverse effect; Internal medicine; Renin–angiotensin system; Angiotensin-converting enzyme","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001802731,0.0003431476,0.003602892,0.0004770422,0.0001457038,0.00001763057,0.00007986943,0.0002048324,0.000004881692],"category_scores_gemma":[0.0006381398,0.0002158198,0.0002780526,0.0003209532,0.0005459649,0.0002714487,0.00008858848,0.0004215872,0.000001093259],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005783092,"about_ca_system_score_gemma":0.0001541514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001800461,"about_ca_topic_score_gemma":0.00004448704,"domain_scores_codex":[0.9964001,0.0005998305,0.001687934,0.0003458782,0.0006947657,0.0002715286],"domain_scores_gemma":[0.9968446,0.0008574848,0.0008488707,0.0002836525,0.0009024686,0.0002629241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9768828,0.0006715116,0.002494438,0.00002202144,0.0004183303,0.001339219,0.00200184,0.00002548625,0.01320218,0.00000734565,0.002207041,0.0007278346],"study_design_scores_gemma":[0.9498728,0.003222069,0.03045548,0.001075105,0.0007286661,0.0100858,0.0003145529,0.0005487201,0.002982716,0.00001242967,0.0004613504,0.0002403229],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877324,0.008981869,0.00001030415,0.001052136,0.0005109331,0.001411521,0.000002386775,0.00001492888,0.000283597],"genre_scores_gemma":[0.995538,0.002377011,0.001436179,0.0001360143,0.0004000838,0.000005643645,0.000005038885,0.00002740868,0.00007464783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02796104,"threshold_uncertainty_score":0.8800877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1144904889713115,"score_gpt":0.3234437671024428,"score_spread":0.2089532781311313,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}